Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects
Ramírez Sevilla, Cristóbal, Gómez Lanza, Esther, Manzanera, Juan Llopis, Martín, Jose Antonio Romero, Sanz, Miguel Ángel BarrancoVolume:
19
Language:
english
Journal:
BMC Infectious Diseases
DOI:
10.1186/s12879-019-4541-y
Date:
December, 2019
File:
PDF, 949 KB
english, 2019